[Note: Nitrosative stress is the damage to a cell or organism resulting from exposure to high levels of nitric oxide or peroxynitrite – a concept of interest to many now studying “unexplained illnesses.”]
It has been shown that chronic fatigue syndrome (CFS) and major depression (MDD) are accompanied by signs of oxidative stress and by a decreased antioxidant status. The aim of the present study was to examine whether CFS and MDD are accompanied by an IgM-mediated immune response directed against nitro-serum bovine albumin (BSA), which is a neoepitope of BSA formed by damage caused by nitrosative stress.
Toward this end, we examined serum IgM antibodies to nitro-BSA in 13 patients with CFS, 14 subjects with partial CFS, 16 patients with MDD and 11 normal controls.
We found that the prevalence and mean values for the serum IgM levels directed against nitro-BSA were significantly greater in patients with partial CFS, CFS and MDD than in normal controls, and significantly greater in CFS than in those with partial CFS and MDD.
We found significant and positive correlations between serum IgM levels directed against nitro-BSA and symptoms of the FibroFatigue scale, i.e. aches and pain and muscular tension.
There was also a strong positive correlation between serum IgM titers directed against nitro-BSA and an index of increased gut permeability ("leaky gut"), i.e. serum IgM and IgA directed against LPS of different gram-negative enterobacteria. [LPS is lipopolysaccharide, a major component of the gram-negative bacteria's outer membrane.]
The abovementioned results indicate that both CFS and MDD are accompanied by:
a) An increased gut permeability which has allowed an exaggerated passage of BSA through a compromised epithelial barrier;
b) Increased nitrosative stress which has induced damage to BSA; and
c) An IgM-mediated immune response which is directed against the nitro-BSA neoepitopes.
Nitrosative stress is one of the factors underpinning the comorbidity and clinical overlap between CFS and major depression.
Source: Neuro Endocrinology Letters. Jun 2008; 29(3):313-319. PMID: 18580855, by Maes M, Mihaylova I, Kubera M, Leunis JC. MCare4U Outpatient Clinics, Belgium; Department of Endocrinology, Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland; Laboratory Ategis, Wavre, Belgium. [E-mail: firstname.lastname@example.org]